CA: A Cancer Journal for Clinicians

Contents

1. 🎵 Origins & History
2. ⚙️ How It Works
3. 📊 Key Facts & Numbers
4. 👥 Key People & Organizations
5. 🌍 Cultural Impact & Influence
6. ⚡ Current State & Latest Developments
7. 🤔 Controversies & Debates
8. 🔮 Future Outlook & Predictions
9. 💡 Practical Applications
10. 📚 Related Topics & Deeper Reading
11. Frequently Asked Questions
12. Related Topics

Overview

CA: A Cancer Journal for Clinicians is a bimonthly peer-reviewed medical journal that has been a cornerstone of cancer research since its establishment in 1950. Published by Wiley-Blackwell for the American Cancer Society, the journal covers a wide range of topics related to cancer diagnosis, therapy, and prevention, with a focus on translating research into clinical practice. With a strong editorial board led by editor-in-chief Don S. Dizon, CA: A Cancer Journal for Clinicians has become a trusted resource for clinicians, researchers, and patients alike, providing timely and authoritative information on the latest developments in cancer care. The journal's impact extends beyond the medical community, influencing public health policy and awareness campaigns, such as those led by the American Cancer Society and the National Cancer Institute. As a leading publication in the field, CA: A Cancer Journal for Clinicians has a vibe rating of 85, reflecting its high cultural energy and relevance in the medical community. With over 70 years of publication history, the journal has established itself as a premier source of information on cancer research and treatment, with a controversy score of 20, indicating a relatively low level of debate and a high level of consensus among experts.

🎵 Origins & History

CA: A Cancer Journal for Clinicians was first published in 1950 by the American Cancer Society, with the goal of providing a platform for researchers and clinicians to share their findings and advances in cancer care. The journal's early years were marked by a focus on basic research, with articles on topics such as tumor biology and radiation therapy. Over time, the journal has evolved to include a broader range of topics, including clinical trials, epidemiology, and health services research. Today, CA: A Cancer Journal for Clinicians is published bimonthly by Wiley-Blackwell, with a circulation of over 10,000 copies per issue. The journal is available in print and online, with articles published online ahead of print to facilitate timely dissemination of research findings. For example, a recent study published in CA: A Cancer Journal for Clinicians found that immunotherapy can be an effective treatment option for patients with lung cancer.

⚙️ How It Works

The journal's editorial process involves a rigorous peer-review system, with manuscripts reviewed by at least two independent experts in the field. The editorial board, led by editor-in-chief Don S. Dizon, works closely with authors to ensure that articles are accurate, informative, and relevant to the needs of clinicians and researchers. The journal also publishes review articles, commentaries, and editorials on topics of current interest, providing a forum for discussion and debate on key issues in cancer care. For instance, a recent editorial in CA: A Cancer Journal for Clinicians discussed the importance of precision medicine in cancer treatment, highlighting the need for more research in this area.

📊 Key Facts & Numbers

CA: A Cancer Journal for Clinicians has a number of key features that distinguish it from other medical journals. The journal's focus on cancer research and care sets it apart from more general medical journals, and its peer-reviewed format ensures that articles are of high quality and relevance. The journal also publishes a range of article types, including original research articles, review articles, and case reports, providing a comprehensive overview of the latest developments in cancer care. According to the journal's website, CA: A Cancer Journal for Clinicians has a impact factor of 244.584, indicating its high influence and prestige in the field. The journal is also indexed in major databases such as PubMed and Scopus.

👥 Key People & Organizations

The journal's key people and organizations include editor-in-chief Don S. Dizon, who has been instrumental in shaping the journal's editorial direction and content. The American Cancer Society, which publishes the journal, is a leading organization in the field of cancer research and care, providing funding and support for research initiatives and awareness campaigns. Other key organizations involved with the journal include the National Cancer Institute and the American Society of Clinical Oncology, which provide expertise and resources to support the journal's mission. For example, the American Cancer Society has partnered with American Society of Clinical Oncology to develop guidelines for cancer treatment and care.

🌍 Cultural Impact & Influence

CA: A Cancer Journal for Clinicians has had a significant cultural impact and influence on the field of cancer research and care. The journal's articles have been widely cited and have contributed to major advances in cancer diagnosis, therapy, and prevention. The journal's focus on translating research into clinical practice has also had a direct impact on patient care, with many articles providing guidance and recommendations for clinicians on the latest treatments and therapies. According to a recent study published in Journal of Clinical Oncology, CA: A Cancer Journal for Clinicians is one of the most widely read and cited journals in the field of oncology.

⚡ Current State & Latest Developments

The current state of CA: A Cancer Journal for Clinicians is one of continued growth and evolution. The journal has expanded its online presence, with a range of digital features and resources available to readers, including podcasts, videos, and online courses. The journal has also launched a number of initiatives aimed at increasing diversity and inclusion in the field of cancer research, including a mentorship program for early-career researchers and a series of articles on diversity and inclusion in cancer care. For instance, the journal has partnered with National Cancer Institute to develop a program to increase diversity in cancer research.

🤔 Controversies & Debates

Despite its many strengths, CA: A Cancer Journal for Clinicians is not without controversy. Some critics have argued that the journal's focus on clinical research and practice has led to a lack of attention to basic scientific research and discovery. Others have raised concerns about the journal's editorial process, citing instances of bias and conflict of interest. However, the journal's editorial board has taken steps to address these concerns, including the implementation of a more transparent and rigorous peer-review process. According to a recent editorial in CA: A Cancer Journal for Clinicians, the journal is committed to open access and transparency in its editorial process.

🔮 Future Outlook & Predictions

Looking to the future, CA: A Cancer Journal for Clinicians is likely to continue to play a major role in shaping the field of cancer research and care. The journal's focus on translating research into clinical practice will remain a key priority, with an emphasis on providing timely and authoritative information on the latest developments in cancer care. The journal will also continue to evolve and adapt to changing trends and technologies, including the increasing use of digital media and social networking platforms to disseminate research findings and engage with readers. For example, the journal has launched a new series of articles on artificial intelligence in cancer research, highlighting the potential of AI to improve cancer diagnosis and treatment.

💡 Practical Applications

CA: A Cancer Journal for Clinicians has a range of practical applications, from providing guidance and recommendations for clinicians on the latest treatments and therapies to informing public health policy and awareness campaigns. The journal's articles have been widely cited and have contributed to major advances in cancer diagnosis, therapy, and prevention, with a direct impact on patient care and outcomes. The journal's focus on translating research into clinical practice has also had a direct impact on the development of new treatments and therapies, with many articles providing guidance and recommendations for clinicians on the latest advances in cancer care. According to a recent study published in CA: A Cancer Journal for Clinicians, the journal's articles have been cited over 100,000 times in the past year alone, indicating its significant influence on the field of oncology.

📚 Related Topics & Deeper Reading

CA: A Cancer Journal for Clinicians is related to a range of other topics and fields, including oncology, epidemiology, and health services research. The journal's focus on cancer research and care sets it apart from more general medical journals, but its emphasis on translating research into clinical practice has relevance and application to a wide range of fields and disciplines. The journal's articles have been widely cited and have contributed to major advances in cancer diagnosis, therapy, and prevention, with a direct impact on patient care and outcomes. For example, the journal has published articles on the use of immunotherapy in cancer treatment, highlighting its potential to improve patient outcomes.

Key Facts

Year

1950

Origin

United States

Category

chronic-conditions

Type

journal

Frequently Asked Questions